StockData
Nu Skin Enterprises, Inc. logo

Nu Skin Enterprises, Inc. (NUS) stock

NUSNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 12/3069% below fair value
$3.78−0.15 (-3.82%)

Close on Nov 17, 2026Market cap $184.00MP/E –Yield –

Nu Skin Enterprises total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Nu Skin Enterprises's total debt was $203.73M at Sep 30, 2026. For fiscal 2025 it was $224.19M, down 43.0% from the year before. Over ten years it grew -1.1% a year on average. The highest annual figure on record is $503.04M in fiscal 2023.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$224.19M-43.0%
FY2024Dec 31, 2024$393.61M-21.8%
FY2023Dec 31, 2023$503.04M+25.0%
FY2022Dec 31, 2022$402.47M+7.0%
FY2021Dec 31, 2021$376.28M+12.2%
FY2020Dec 31, 2020$335.39M-7.3%
FY2019Dec 31, 2019$361.96M-15.9%
FY2018Dec 31, 2018$430.46M+10.8%
FY2017Dec 31, 2017$388.63M-6.8%
FY2016Dec 31, 2016$416.89M+67.0%
FY2015Dec 31, 2015$249.59M+0.9%
FY2014Dec 31, 2014$247.34M+36.1%
FY2013Dec 31, 2013$181.68M-6.3%
FY2012Dec 31, 2012$193.98M+42.1%
FY2011Dec 31, 2011$136.55M-15.1%
FY2010Dec 31, 2010$160.88M+2.8%
FY2009Dec 31, 2009$156.52M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$203.73M-11.1%
Q2 FY2026Jun 30, 2026$213.66M-14.2%
Q1 FY2026Mar 31, 2026$223.59M-6.4%
Q4 FY2025Dec 31, 2025$224.19M-43.0%
Q3 FY2025Sep 30, 2025$229.04M-47.2%
Q2 FY2025Jun 30, 2025$248.90M-45.7%
Q1 FY2025Mar 31, 2025$238.76M-50.6%
Q4 FY2024Dec 31, 2024$393.61M-21.8%
Q3 FY2024Sep 30, 2024$433.47M-13.8%
Q2 FY2024Jun 30, 2024$458.33M-9.7%
Q1 FY2024Mar 31, 2024$483.18M+15.0%
Q4 FY2023Dec 31, 2023$503.04M+25.0%
Q3 FY2023Sep 30, 2023$502.90M+18.4%
Q2 FY2023Jun 30, 2023$507.75M+18.9%
Q1 FY2023Mar 31, 2023$420.11M+13.9%
Q4 FY2022Dec 31, 2022$402.47M+7.0%
Q3 FY2022Sep 30, 2022$424.82M+9.3%
Q2 FY2022Jun 30, 2022$427.18M-3.1%
Q1 FY2022Mar 31, 2022$369.00M-4.9%
Q4 FY2021Dec 31, 2021$376.28M+12.2%
Q3 FY2021Sep 30, 2021$388.56M+13.4%
Q2 FY2021Jun 30, 2021$440.84M+6.2%
Q1 FY2021Mar 31, 2021$388.12M-8.1%
Q4 FY2020Dec 31, 2020$335.39M-7.3%
Q3 FY2020Sep 30, 2020$342.66M-6.6%
Q2 FY2020Jun 30, 2020$414.93M+1.6%
Q1 FY2020Mar 31, 2020$422.20M+5.2%
Q4 FY2019Dec 31, 2019$361.96M-15.9%
Q3 FY2019Sep 30, 2019$366.72M-18.2%
Q2 FY2019Jun 30, 2019$408.49M-12.7%
Q1 FY2019Mar 31, 2019$401.25M-14.6%
Q4 FY2018Dec 31, 2018$430.46M+10.8%
Q3 FY2018Sep 30, 2018$448.22M+7.2%
Q2 FY2018Jun 30, 2018$468.01M+10.2%
Q1 FY2018Mar 31, 2018$469.93M+9.7%
Q4 FY2017Dec 31, 2017$388.63M-6.8%
Q3 FY2017Sep 30, 2017$418.22M–
Q2 FY2017Jun 30, 2017$424.59M–
Q1 FY2017Mar 31, 2017$428.48M–
Q4 FY2016Dec 31, 2016$416.89M–

More Nu Skin Enterprises figures

See a number that looks wrong?